## BACKGROUND. Pancreatic cancer is an aggressive disease and its patients typically have a short survival, usually marked by pain and rapid debilitation. 'The disease has been considered relatively chemoresistant, although many chemotherapy regimens have been described. METHODS. Clinical results
Chemotherapy of pancreatic carcinoma
โ Scribed by Steven E. Zimmerman; Frederick P. Smith; Philip S. Schein
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 511 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Pancreatic cancer is an aggressive disease and its patients typically have a short survival, usually marked by pain and rapid debilitation. 'The disease has been considered relatively chemoresistant, although many chemotherapy regimens have been described. METHODS. Clinical results
## BACKGROUND. Survival for adenocarcinoma of the pancreatic remains unchanged over the last two decades. The majority of patients (85%) are diagnosed with an inoperable tumor. Patterns of failure reveal that pancreatic cancer involves three compartments: the pancreatic bed and regional lymph nodes
## BACKGROUND. Survival for adenocarcinoma of the pancreatic remains unchanged over the last two decades. The majority of patients (85%) are diagnosed with an inoperable tumor. Patterns of failure reveal that pancreatic cancer involves three compartments: the pancreatic bed and regional lymph node
The use of radiation therapy combined with 5-fluorouracil (5-FU) in the treatment of pancreatic cancer has been well established. It has been hypothesized that any benefit from combined 5-FU and radiation has been due to radiosensitization. Improved therapy could result from a better understanding o